Guided Therapeutics, Inc.
GTHP
$0.29
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -89.46% | 34.51% | 0.31% | 7.76% | -76.37% |
| Total Depreciation and Amortization | 8.00% | 4.17% | 0.00% | 0.00% | 4.35% |
| Total Amortization of Deferred Charges | 1.49% | 219.05% | -4.55% | 22.22% | -43.75% |
| Total Other Non-Cash Items | 2,820.00% | -- | -100.00% | 135.71% | 115.38% |
| Change in Net Operating Assets | 1,850.00% | -94.91% | 298.55% | -83.76% | 81.62% |
| Cash from Operations | 48.94% | 0.30% | 29.81% | -121.03% | -114.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 73.17% | 2.50% | 6.95% | -6.50% | -- |
| Total Debt Repaid | 51.70% | 29.67% | -151.81% | 40.29% | -202.17% |
| Issuance of Common Stock | -- | -- | 78.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 29.41% | -- |
| Cash from Financing | 312.07% | -88.97% | 34.18% | 790.91% | 195.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.64% | -240.72% | 339.51% | 52.35% | -16.44% |